News Headlines Article

Increasing transparency on generic drug cost data could save $4 billion
Modern Healthcare

Increasing transparency on the cost of generic drugs could save about $4 billion a year in overall healthcare spending in the U.S., according to a new paper. Making actual generic drug acquisition costs available to third-party payers would empower health plans to negotiate lower rates and essentially level the playing field in a pharmaceutical supply chain that’s shrouded in secrecy. Ultimately, patients would pay less at the expense of pharmacy benefit mangers’ profits, researchers said.